Origin |
China |
Model Number |
49673-81-6 |
Brand Name |
HONO |
Product name: L-Lysine-S-Carboxy Methyl-L-Cysteine
Synonyme: L-Carbocysteine-Lysine, SCMC-Lys
CAS#: 49673-81-6
Molecular Formula: C6H14N2O2.C5H9NO4S
Specification:
|
Item
|
Specification
|
|
Description
|
Ivory white or white powder
|
|
Specific rotation[α]D20
|
-13.2°~ -15.2°
|
|
Assay
|
98.0~101.5%
|
|
Impurity
|
NMT 0.2%
|
|
Melting point
|
178��181��/div>
|
|
Moisture
|
4.0~6.0%
|
|
IR
|
Meet with the requirements
|
Function:
Carbocysteine lysine salt monohydrate (SCMC-Lys) is a well-known mucoactive drug whose therapeutic efficacy is commonly related to the ability of SCMC-Lys to replace fucomucins by sialomucins. The aim of this study was to determine if SCMC-Lys couldexert an anti-oxidant action by scavenging reactive oxygen intermediates (ROIs). Our results show that SCMC-Lys proved effective as a selective scavenger of hypochlorous acid (HOCl) and hydroxyl radical (OH.), this effect being related to the reactivity of the SCMC tioether group. The scavenger activity of SCMC-Lys was observed in free cellular system as well as in activated human polymorphonuclear neutrophils (PMNs). SCMC-Lys scavenger activity on HOCl was paralleled by a powerful protection from HOCl-mediated inactivation ofalpha1-antitripsin (alpha1-AT) inhibitor, the main serum protease inhibitor. Production of interleukin-(IL-)8, a major mediator of PMN recruitment in inflammatory diseases, is known to be mediated by intracellular OH.SCMC-Lys significantly reduced IL-8 production on stimulated human peripheral blood mononuclear cells (PBMCs) in the same range of concentrations affecting OH. activity. It is concluded that SCMC-Lys could exert, in addition to its mucoactive capacity, an anti-oxidant action, thus contributing to the therapeutic efficacy of SCMC-Lys.
|